Cline Christopher R. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$301,761.22

Insider Activity of Cline Christopher R.

According to the SEC Form 4 filings, Cline Christopher R., being in a position of

  1. CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 90955 shares for $4.64M,
    over all time since 2023-01-24, has bought 0 shares, and sold 111015 shares for $4.96M.

Biography of Cline Christopher R.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,644,47910100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
50,508
0.0542%
$62.34$3.15M-15.55%
2026-09-02SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
642
0.0007%
$66.37$42,610-15.44%
2026-05-06SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
310
0.0003%
$43.95$13,625+25.87%
2026-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
2,181
0.0024%
$46.65$101,744+25.7%
2026-04-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
1,014
0.0015%
$42.61$43,207+36.08%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
7,248
0.0105%
$41.93$303,892+31.88%
2026-04-13SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
65
<0.0001%
$28.85$1,875+80.83%
2026-02-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
1,745
0.002%
$32.19$56,168+59.22%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
7,242
0.0079%
$32.12$232,613+53.44%
2025-12-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
20,000
0.0222%
$35.01$700,202+26.43%
2025-09-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
119
0.0001%
$19.71$2,345+65.89%
2025-09-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
454
0.0005%
$18.20$8,263+78.51%
2025-08-27SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
470
0.0005%
$17.31$8,136+99.14%
2025-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
1,784
0.002%
$21.05$37,553+29.47%
2025-04-11SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
48
<0.0001%
$13.14$631+80.69%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
5,192
0.0059%
$20.12$104,463+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
865
0.001%
$18.94$16,384+6.94%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
2,490
0.0029%
$11.52$28,685+37.44%
2024-09-04SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
514
0.0006%
$9.51$4,888+75.22%
2024-04-11SaleTravere Therapeutics, Inc.
TVTX
CHIEF FINANCIAL OFFICER
54
<0.0001%
$6.74$364+126.76%
Total: 27
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.